Health Condition 1: H42- Glaucoma in diseases classified elsewhere
Conditions
Interventions
Intervention1: Oral curcumin capsule: One (1) capsule of curcumin will be given orally /per day for three (3) months, Curcumin acts as an anti-oxidative and anti-inflammatory agent.
Control Interventi
Sponsors
All India Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: The following patients will be included in the study 1.Patients willing to give consent for the study 2.Age 18 to 80 years. 3.Patients with advanced stage glaucoma in at least one eye and well-controlled IOP (less than 16 mmHg) in that eye with a Snellen visual acuity of at least 6 by 36. 4.If both eyes of the patient were eligible the eye with the better visual field was included in the study
Exclusion criteria
Exclusion criteria: 1.Not willing to follow up. 2.Age less than 18 years 3.Any patient with recent ocular surgery in past 3 months or secondary inflammatory conditions causing glaucoma eg, vernal keratoconjunctivitis (VKC), uveitix, sclerouveitis etc. 4.Patients with contraindications to curcumin or any related allergies. 5.Patients with any other disease that might have contributed to visual field loss at the time of initial visual-field test such as other optic neuropathies, stroke, brain tumors, retinal vein or artery occlusion, macular disease, cataract and proliferative diabetic retinopathy. 6.Any recent surgery in last 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Perimetry 2.Cup-Disc-Ratio (CDR) 3.Optical Coherence Tomography Angiography (OCTA) Timepoint: 4 Weeks, 6 Weeks, 12 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Multifocal Electroretinography (Mf-erg)Timepoint: 4 Weeks, 6 Weeks, 12 Weeks | — |
Countries
India
Contacts
Public ContactShikha Gupta
Aiims, New Delhi
Outcome results
None listed